All Relations between dopaminergic and dopamine

Publication Sentence Publish Date Extraction Date Species
D Jovanović-Mićić, R Samardzić, D B Belesli. The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis. European journal of pharmacology. vol 272. issue 1. 1995-05-16. PMID:7713146. it appears, therefore, that the emetic effect of intracerebroventricular dopamine is mediated by adrenergic rather than dopaminergic mechanisms in the area postrema, at least in the cat. 1995-05-16 2023-08-12 cat
A Espino, J Llorens, M Calopa, R Bartrons, E Rodriguez-Farré, S Ambrosi. Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion. Brain research. vol 669. issue 1. 1995-05-12. PMID:7712161. it is concluded that the concentration of dopamine metabolites in csf can be altered only after a severe striatal lesion: reduction of striatal dopamine content below 50% of normal values and involvement of neuronal or non-neuronal elements other than the dopaminergic system, similarly to the lesions caused by mpp+. 1995-05-12 2023-08-12 rat
J A St-Pierre, P J Bédar. Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine. European journal of pharmacology. vol 272. issue 2-3. 1995-05-12. PMID:7713155. systemic administration of the non-competitive antagonist of nmda receptors mk-801 ((+)-5-methyl-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5,10-imine) potentiates the circling response induced by direct stimulation of the striatal dopaminergic receptors through intracerebral application of dopamine. 1995-05-12 2023-08-12 rat
J A St-Pierre, P J Bédar. Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine. European journal of pharmacology. vol 272. issue 2-3. 1995-05-12. PMID:7713155. the results suggest that the potentiation by nmda receptor antagonists of motor activity induced by dopaminergic agonists in animal models of parkinson's disease cannot be ascribed simply to increased release of dopamine. 1995-05-12 2023-08-12 rat
A M Lew, H P Elsholt. A dopamine-responsive domain in the N-terminal sequence of Pit-1. Transcriptional inhibition in endocrine cell types. The Journal of biological chemistry. vol 270. issue 13. 1995-05-10. PMID:7706253. to study the role of pit-1 in dopaminergic inhibition of the prolactin gene, we transiently transfected pit-1 and dopamine d2 receptor vectors into a series of heterologous cell lines and examined dopamine regulation of the prolactin gene promoter. 1995-05-10 2023-08-12 Not clear
M Kohzuma, Y Kataoka, S Koizumi, H Shibaguchi, M N Nakashima, K Yamashita, M Niwa, K Taniyam. ETB receptor involvement in stimulatory and neurotoxic action of endothelin on dopamine neurones. Neuroreport. vol 5. issue 18. 1995-05-04. PMID:7696625. we examined the role of endothelin (et) receptor subtypes in mediating the transient and sustained release of dopamine (da) evoked by ets and et-1-induced dopaminergic dysfunction in rat striatal slices. 1995-05-04 2023-08-12 rat
I Chaudieu, J A St-Pierre, R Quirion, P Boks. GABAA receptor-mediated inhibition of N-methyl-D-aspartate-evoked [3H]dopamine release from mesencephalic cell cultures. European journal of pharmacology. vol 264. issue 3. 1995-04-28. PMID:7698177. however systemic or intra-ventral tegmental administration of a gabaa receptor agonist produces paradoxical depolarization of mesencephalic dopaminergic neurons and increases dopamine release. 1995-04-28 2023-08-12 rat
P Remy, A de Recondo, G Defer, C Loc'h, P Amarenco, V Planté-Bordeneuve, M H Dao-Castellana, B Bendriem, C Crouzel, M Clane. Peduncular 'rubral' tremor and dopaminergic denervation: a PET study. Neurology. vol 45. issue 3 Pt 1. 1995-04-27. PMID:7898699. our results indicate an important involvement of the nigral dopaminergic system in peduncular tremors that appears to be independent of postsynaptic dopamine receptors. 1995-04-27 2023-08-12 Not clear
M Kudernatsch, B Suto. Cholinergic modulation of dopamine overflow in the rat neostriatum: a fast cyclic voltammetric study in vitro. Neuroscience letters. vol 181. issue 1-2. 1995-04-27. PMID:7898747. phasic) dopamine overflow in vitro by affecting striatal dopaminergic nerve terminals. 1995-04-27 2023-08-12 rat
M B Knable, T M Hyde, M M Herman, J M Carter, L Bigelow, J E Kleinma. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients. Biological psychiatry. vol 36. issue 12. 1995-04-26. PMID:7893846. a number of previously published homogenate receptor binding studies have postulated that dopaminergic dysfunction in schizophrenia may be related to abnormalities in dopamine receptors. 1995-04-26 2023-08-12 Not clear
S Ferré, W T O'Connor, P Snaprud, U Ungerstedt, K Fux. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience. vol 63. issue 3. 1995-04-26. PMID:7898676. a tonic dopaminergic modulation of the striopallidal neurons from the ventral striopallidal system was demonstrated by a dual-probe approach, by infusing selective dopamine agonists and antagonists in the nucleus and by measuring dopamine extracellular levels in the nucleus accumbens and gaba extracellular levels in the nucleus accumbens and in the ipsilateral ventral pallidum. 1995-04-26 2023-08-12 rat
H Moukhles, M Amalric, A Nieoullon, A Daszut. Behavioural recovery of rats grafted with dopamine cells after partial striatal dopaminergic depletion in a conditioned reaction-time task. Neuroscience. vol 63. issue 1. 1995-04-25. PMID:7898663. behavioural recovery of rats grafted with dopamine cells after partial striatal dopaminergic depletion in a conditioned reaction-time task. 1995-04-25 2023-08-12 rat
H Moukhles, M Amalric, A Nieoullon, A Daszut. Behavioural recovery of rats grafted with dopamine cells after partial striatal dopaminergic depletion in a conditioned reaction-time task. Neuroscience. vol 63. issue 1. 1995-04-25. PMID:7898663. in the present model for partial dopamine depletion of the striatum, the mechanisms underlying the graft-induced recovery probably involve the participation of endogenous dopamine neurons acting in addition to, and/or in synergy with the dopamine-rich grafted tissue so that a functional level of dopaminergic transmission is restored in transplanted animals. 1995-04-25 2023-08-12 rat
G Y Ng, B F O'Dowd, S R Georg. Genotypic differences in brain dopamine receptor function in the DBA/2J and C57BL/6J inbred mouse strains. European journal of pharmacology. vol 269. issue 3. 1995-04-24. PMID:7895774. these lines of evidence provide a basis for the hypothesis that a genetically determined brain dopaminergic deficit mediated by dopamine d1-d2 receptor mechanisms may be involved in at least a part of the risk for ethanol abuse in the c57 inbred mouse strain. 1995-04-24 2023-08-12 mouse
G Y Ng, S R Georg. Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse. European journal of pharmacology. vol 269. issue 3. 1995-04-24. PMID:7895775. dopamine receptor agonist-induced increases in forebrain dopaminergic activity was compensated with increased dopamine d2 receptor density and correspondingly higher dopamine d2 receptor mrna content in the brain stem. 1995-04-24 2023-08-12 mouse
B J Ciliax, C Heilman, L L Demchyshyn, Z B Pristupa, E Ince, S M Hersch, H B Niznik, A I Leve. The dopamine transporter: immunochemical characterization and localization in brain. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 15. issue 3 Pt 1. 1995-04-20. PMID:7534339. however, certain mismatches between immunocytochemical distributions of dat and tyrosine hydroxylase were apparent, indicating that dopaminergic systems are heterogeneous and may use independent mechanisms for the regulation of dopamine levels in brain. 1995-04-20 2023-08-12 human
S M Phelps, V D Ramire. Unilateral deficits induced in rats by MPP+ are markedly reduced by an N-terminal peptide fragment of dopamine-releasing protein. Brain research. vol 666. issue 1. 1995-04-20. PMID:7889360. striatal delivery of 1 microgram darpp-36aa daily for 10 days elevated striatal dopamine (p < 0.01) and reduced amphetamine-induced rotations (p < 0.05) relative to controls, both indicating the protection or restoration of dopaminergic function. 1995-04-20 2023-08-12 rat
J Hietala, C West, E Syvälahti, K Någren, P Lehikoinen, P Sonninen, U Ruotsalaine. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology. vol 116. issue 3. 1995-04-20. PMID:7892418. the result is compatible with a reduced avidity of striatal dopamine d2 receptors in alcoholics, which is in line with the idea that d2 dopaminergic mechanisms are involved in the biology of alcohol dependence in man. 1995-04-20 2023-08-12 human
M D Berry, E Scarr, M Y Zhu, I A Paterson, A V Juori. The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamine. British journal of pharmacology. vol 113. issue 4. 1995-04-19. PMID:7889269. these results suggest that pe can act as a neuromodulator of dopaminergic responses and that mao-b inhibitors may potentiate neuronal responses to dopamine via the indirect mechanism of elevation of pe following mao-b inhibition. 1995-04-19 2023-08-12 rat
L K Nisenbaum, S T Kitai, C R Gerfe. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine. Neuroscience. vol 63. issue 2. 1995-04-18. PMID:7534387. dopaminergic and muscarinic regulation of striatal enkephalin and substance p messenger rnas following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine. 1995-04-18 2023-08-12 rat